Information Provided By: 
Fly News Breaks for December 2, 2016
HSTM
Dec 2, 2016 | 08:00 EDT
As reported previously, Baird analyst Matthew Gillmor upgraded HealthStream to Outperform from Neutral citing its favorable positioning for a defensive environment, a long runway for growth, a fading of its headwinds in 2018, and its compelling valuation. Gillmor raised his price target to $31 from $26 on HealthStream shares.
News For HSTM From the Last 2 Days
There are no results for your query HSTM
